Back to BBIO

Catalio Capital Management, LP → BBIO

Catalio Capital Management, LP BBIO Position History

BridgeBio Pharma, Inc. • Healthcare

Quarters held
4
Latest value
$33.9M
Q2 2026
Peak value
$33.9M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$32.3M
Q4 2025$31.4M
Q1 2026$32.1M
Q2 2026$33.9M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q2 2026$33.9M455.0K——
Q1 2026$32.1M432.0K——
Q4 2025$31.4M410.7K——
Q3 2025$32.3M622.7K——

Other funds holding BBIO

Other Catalio Capital Management, LP positions

AVLN

AVALYN PHARMACEUTICALS INC

$55.2M
DNTH

DIANTHUS THERAPEUTICS INC

$47M
LLY

ELI LILLY & CO

$43.8M
ABBV

ABBVIE INC

$35.9M
GILD

GILEAD SCIENCES INC

$35.5M
GILD

GILEAD SCIENCES INC

$35.5M
JNJ

JOHNSON & JOHNSON

$35.3M
CELG-RI

BRISTOL-MYERS SQUIBB CO

$34.9M